Trade Summary

4 days ago, Ticho Barry, serving as CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 1,795 shares at $30.58 per share, for a total transaction value of $54,891.10. Following this transaction, Ticho Barry now holds 34,826 shares of STOK.

This sale represents a 4.90% decrease in Ticho Barry's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 5:33 PM ET, 2 days after the trade was made.

Stoke Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.